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OBJECTIVE—Pancreas organogenesis is orchestrated by inter-
actions between the epithelium and the mesenchyme, but these
interactions are not completely understood. Here we investi-
gated a role for bone morphogenetic protein (BMP) signaling
within the pancreas mesenchyme and found it to be required for
the normal development of the mesenchyme as well as for the
pancreatic epithelium.
RESEARCH DESIGN AND METHODS—We analyzed active
BMP signaling by immunostaining for phospho-Smad1,5,8 and
tested whether pancreas development was affected by BMP
inhibition after expression of Noggin and dominant negative
BMP receptors in chicken and mouse pancreas.
RESULTS—Endogenous BMP signaling is conﬁned to the mes-
enchyme in the early pancreas and inhibition of BMP signaling
results in severe pancreatic hypoplasia with reduced epithelial
branching. Notably, we also observed an excessive endocrine
differentiation when mesenchymal BMP signaling is blocked,
presumably secondary to defective mesenchyme to epithelium
signaling.
CONCLUSIONS—We conclude that BMP signaling plays a
previously unsuspected role in the mesenchyme, required for
normal development of the mesenchyme as well as for the
epithelium. Diabetes 59:1948–1956, 2010
I
n the mouse and chicken, the pancreas originates
from dorsal and ventral anlage in the endoderm, ﬁrst
recognized as thickenings of the epithelium which
progress to form bud-like structures at e9.5 in the
mouse and at e3 in the chicken embryo (1). Establishment
of the pancreas territory depends on sequential signals
from lateral plate mesoderm, notochord, and endothelial
cells from the dorsal aorta (2–4), and requires massive
rearrangements of these structures by largely unknown
mechanisms. Dependent on secreted mesenchymal fac-
tors, these buds will expand and start a branching mor-
phogenesis beginning at e12.5 in the mouse and e4 in the
chicken. At the same time, the gut rotates, bringing the
dorsal and ventral pancreas together, and by e12.5 in
the mouse and e5.5 in the chicken, these buds have fused
to form one organ (1,5). The balance between cellular
differentiation and progenitor expansion is controlled by
Notch signaling (6–8), and secreted mesenchymal Fgf10
appears to be involved in maintenance of the progenitor
cell pool (9–11).
Few mesenchymal factors involved in pancreas devel-
opment have been identiﬁed despite the long acknowl-
edged role of epitheliomesenchymal interactions (12,13).
Studies on other organ systems, such as the lung, have
demonstrated that members of the transforming growth
factor- superfamily are important mediators of signals
between epithelia and mesenchyme in a range of organ-
isms (14). Several factors from this family have been
reported to be expressed in the developing mouse pan-
creas, including bone morphogenetic proteins (BMPs)
BMP4, BMP5, and BMP7 and their cognate receptors
(15,16). BMP4 signaling through ALK3 was recently re-
ported to be involved in glucose-stimulated insulin secre-
tion in the adult pancreas (16). However, little is known
about the role of BMP signaling during embryonic pan-
creas development.
Here we report that BMP signaling to the mesenchyme
is crucial for development of the pancreas. We show that
BMP signaling determined by pSmad1,5,8 immunoreactiv-
ity is restricted to the mesenchyme during early pancreas
development. Inhibition of BMP signaling in vivo by Nog-
gin results in reduced epithelial branching and increased
endocrine differentiation. This coincides with a severe
failure of vascular remodeling and mesenchymal morpho-
genesis. The effect of Noggin on endocrine differentiation
can be mimicked by cell autonomous BMP signaling
inhibition in the mouse pancreas mesenchyme using len-
tiviral transduction in vitro.
RESEARCH DESIGN AND METHODS
In ovo electroporation and in situ hybridization was performed as in previous
studies (6), and at least three embryos were analyzed for each condition. RNA
probes were transcribed in vitro from cDNA clones provided by BBSRC
(Bmp7: ChEST290N8; Bapx1: ChEST177B22; Pitx2: ChEST76C15), except for
the Neurog3 cDNA provided by Anne Grapin-Botton and the Bmp4 cDNA
provided by Cliff Tabin. Probes for Nkx6.1 and Hes1 were used as in earlier
studies (6,17) The Xenopus Noggin cDNA was provided by Richard Harland,
and a COOH-terminal cMyc epitope tag inserted by PCR. The mouse dnALK3
was a COOH-terminal truncated receptor (encoding aa 1–237) lacking the
kinase domain. A similar construct has previously been used to block BMP
signaling in duck and chicken embryos (18). All expression constructs were
cloned into the pCIG5 vector (6).
Whole-mount immunoﬂourescent staining was performed as in (19).
Brieﬂy, embryos were cleared in Dent’s bleach and incubated overnight with
antibodies diluted in blocking buffer. Confocal images were obtained from
embryos cleared in benzyl alcohol/benzyl benzoate (BABB) (19) on a Zeiss
LSM510 AxioImager. For antibodies, these data can be found in online
appendix supplementary Table 1, available at http://diabetes.diabetesjournals.
org/cgi/content/full/db09-1010/DC1. Perfusion of embryos with lens culinaris
agglutinin was performed with a protocol modiﬁed from Jilani et al. (20).
Using this protocol, the embryos were dissected in PBS, and 10 l was
injected into the heart with a pulled glass pipette. The embryos were left for
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1948 DIABETES, VOL. 59, AUGUST 2010 diabetes.diabetesjournals.org5 min, then ﬁxed and processed for immunohistochemistry. Labeled areas
were quantiﬁed using ImageJ software by analyzing every second optical
section corresponding to an optical depth of 20 m through the whole
pancreas (between 7 and 12 sections from each embryos). Statistical signiﬁ-
cance was calculated using Student t test. Results were considered statisti-
cally signiﬁcant if P  0.05.
Lentiviral constructs were generated by gateway recombination cloning,
using entry vectors with the same constructs used in the chicken experiments.
Organs were cultured and transduced as by Attali et al. (21), except that the
epithelium was not separated from the mesenchyme before lentiviral infec-
tion. All lentiviral vectors were used at viral concentrations corresponding to
300 ng of p24 capsid protein per explant. The e12.5-pancreas explants were
ﬁxed in formalin and embedded in parafﬁn 7 days after transduction. The
explants were sectioned (4 m) and stained for insulin, amylase, and DNA
(DAPI) as described by Haumaitre et al. (22). Quantiﬁcation was performed
every ﬁfth section spanning the entire explant using ImageJ software, and
total area, insulin area, and amylase area surface were measured. In the e10.5
gut tube explants 10-m cryosections of the entire explants were stained for
insulin, amylase, and DNA (DAPI). Quantiﬁcation was performed every
second section by counting the nuclei of insulin and amylase-positive cells.
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FIG. 1. pSmad1,5,8 immunoreactivity in the embryonic chicken and mouse pancreas. pSmad1,5,8 stainings on e2, e3, and e4 (HH st.12, 18, and 21)
chicken embryos (A–J), e9.5 mouse embryo (K–L), and e11.5-dissected mouse gut (M–N). A–D: e2 embryo stained in whole mount as indicated.
Images are either projections of confocal z-stacks of thick vibratome sections (A–C) or an optical section (D). Boxed area in B is shown in higher
magniﬁcation in C and D. A: Projected image from a z-stack showing pSmad1,5,8 reactivity in the ventral forgut endoderm (arrows) and dorsal
neural tube (arrowhead). B: Projected image at the presumptive pancreas level. Note pSmad1,5,8 reactivity in the lateral plate mesoderm and
the underlying endoderm that appears yellow because of coexpression with Foxa2 (arrow). C and D: pSmad1,5,8 reactivity can be observed in
the endothelial cells of the dorsal aortas and in endoderm lateral to the Nkx6.1 expression domain (arrowhead). E and F: A section of an e3
pancreas stained as indicated (shown with and without Nkx6.1). Note the pSmad1,5,8 reactivity in the mesenchyme and the absence of staining
in the pancreas epithelium (arrows point to the dorsal pancreas). G: Composite of two images showing the dorsal and ventral pancreas and the
liver; pSmad1,5,8 can be detected in the pancreas mesenchyme and in mesenchymal and epithelial compartments of the liver. Note the sharp
boundary of pSmad1,5,8 in the bile duct (arrows). H–J: Another section from the same pancreas showing absence of pSmad1,5,8 immunoreac-
tivity in the Nkx6.1-positive pancreatic epithelium and -cells (recognizable by their morphology, arrowhead). K and L: Optical sections from a
z-stack of an e9.5 mouse stained in whole mount; pSmad1,5,8 can be detected in the dorsal aorta and intersomitic vessels and in mesenchymal cells
in close contact with the ventral pancreas epithelium. M and N: Optical sections from an e11.5 mouse dissected gut. Note the mesenchymal
pSmad1,5,8 signal. Dashed outline is shown without Pdx1 in the inset. *marks an unspeciﬁc luminal signal from antibody trapping. a, aorta; dp,
dorsal pancreas; duo, duodenum, v, right omphalomesenteric vein; vp, ventral pancreas. (A high-quality digital representation of this ﬁgure is
available in the online issue.)
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numbers. Statistical signiﬁcance was calculated using Student t test. Results
were considered statistically signiﬁcant if P  0.05.
RESULTS
Phospho-Smad1,5,8 immunoreactivity is restricted to the pancreas
mesenchyme. BMP signaling is transduced by Smad1, 5, and 8 which,
upon signaling, become phosphorylated and accumulates in the nucleus
where they act as transcription factors (23). We used a phosphoSmad1,5,8-
speciﬁc antibody (24) to characterize endogenous BMP signaling in the
embryonic chicken pancreas (Fig. 1) at Hamburger and Hamilton (HH) stages
12, 18, and 21 (25). This corresponds to time points when the pancreas has just
been speciﬁed in the endoderm, dorsal and ventral buds have formed, and
-cells, -cells, and amylase-positive cells can be detected (6,17).
At HH st. 12, embryos were whole-mount stained and 200-m transverse
vibratome sections were analyzed (Fig. 1A–D). Nuclear pSmad1,5,8 could be
detected in the dorsal neural tube (Fig. 1A–D) and in the ventral part of the
anterior foregut endoderm (arrows, Fig. 1A,) as previously reported (24). At
the level of the 3rd to 8th somite pairs, where the prospective pancreatic
endoderm is located (3,26), pSmad1,5,8 was detected in the lateral plate
mesoderm and in the endoderm lateral to the Nkx6.1 expression domain (Fig.
1B, arrow, and arrowheads in Fig. 1C and D, supplementary Fig. 1). We could
also observe pSmad1,5,8 in the endothelium of the paired dorsal aortas (Fig.
1C and D).
At HH st. 18, pSmad1,5,8 immunoreactivity was detected in the pancreas
mesenchyme and at lower levels in the duodenal epithelium (Fig. 1E and F).
The dorsal pancreas epithelium was pSmad1,5,8-negative. One day later, we
still observed a mesenchymal pSmad1,5,8 signal (Fig. 1G–J), but no signal was
detected in the dorsal or ventral pancreatic epithelium. The liver epithelium
had a strong signal with a sharp border of immunoreactivity in the bile duct
(Fig. 1G arrows). No pSmad1,5,8 reactivity was detected in Nkx6.1-positive
cells, which at this stage comprise both undifferentiated epithelial cells and
-cells (17) (Fig. 1H–J). The absence of labeling in -cells was conﬁrmed by
colabeling with an insulin antibody (supplementary Fig. 1G and H).
To evaluate the status of Smad1,5,8 phosphorylation in the early mouse
pancreas, we performed whole-mount staining at e9.5 and e11.5 for
pSmad1,5,8 combined with Pdx1 (Fig. 1K–N). At e9.5, immunoreactivity was
detected in the dorsal aortas, intersomitic vessels (Fig. 1K and L), and the
dorsal neural tube (not shown). No pSmad1,5,8 was detected in the Pdx1-
positive endoderm. At e11.5, we observed pSmad1,5,8 reactivity in the
pancreas mesenchyme, but no reactivity in the pancreas epithelium (Fig. 1M
and N). We conclude that endogenous signaling leading to detectable levels of
pSmad1,5,8 in the early chicken and mouse pancreas is entirely restricted to
the mesenchyme.
Several BMPs are expressed in the pancreas mesenchyme. Bmp4,- 5, and
-7 mRNA have been reported to be expressed in the embryonic mouse
pancreas by RT-PCR (15), and Bmp4 and Bmp7 have been localized to the
pancreas epithelium (16), but little is known about BMP expression during
chicken pancreas development. We performed in situ hybridizations at e3
(HH. st. 18) and e4 (HH. st. 22) to characterize the expression patterns of
Bmp2, Bmp4, Bmp5, and Bmp7 (Fig. 2 and data not shown). We found that
Bmp4 and Bmp7 are expressed in the chicken pancreas mesenchyme and
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FIG. 2. Expression patterns of BMPs in the embryonic chicken
pancreas—mRNA ISH, showing the expression of Bmp4 and Bmp7 at
the level of the posterior stomach (in A and C, arrows point at the
dorsal aorta. Arrowheads in A point to mesonephros, and arrowheads
in C point to expression in the stomach mesenchyme) and the pancreas
(B and D) at HH. st. 18. Note that the mesenchymal expression of
Bmp4 and Bmp7 in the pancreas mesenchyme (arrows, B and D). l,
liver; p, pancreas; st. stomach. (A high-quality digital representation of
this ﬁgure is available in the online issue.)
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FIG. 3. Ectopic expression of Noggin in the chicken pancreas epithelium leads to loss of pSmad1,5,8 immunoreactivity in the mesenchyme.
Sectioned pancreata immunolabeled as indicated, 24 h (A–D) and 48 h (E–H) after electroporation. GFP expression is showing transfected cells.
Nkx6.1 is labeling the pancreas. Note the loss of pSMAD1,5,8 in the pancreas mesenchyme around the Noggin transfected area compared with
controls. H: Arrowheads point to pSmad1,5,8 signals maintained at a distance from the electroporated area. dp, dorsal pancreas; vp, ventral
pancreas. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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not shown). We could not detect Bmp2 or Bmp5 in the pancreas at any stage
(data not shown). From these results we concluded that BMP signaling is
active in the pancreas mesenchyme, possibly mediated by BMPs expressed
within the mesenchyme.
Ectopic expression of Noggin in the pancreas leads to loss of
pSmad1,5,8 immunoreactivity and severely affects pancreas develop-
ment. To investigate the requirements for BMP signaling in pancreas devel-
opment, we applied two complementary approaches. We ectopically
expressed the secreted BMP antagonist Noggin or a dominant negative BMP
receptor type 1 (dnALK3) in the pancreas epithelium using in ovo electropo-
ration of the endoderm (6,27). We expected that the secreted antagonist
Noggin should block BMP signaling in the epithelium as well as in the
mesenchyme, whereas dnALK3 should be autonomous to the epithelial cells
expressing this construct. Electroporation was performed at HH st. 10–12,
and the introduced genes were thus expressed soon after the speciﬁcation of
the pancreas endoderm (17).
First we electroporated with a cMYC tagged Noggin in the pCIG5 vector
which has an IRES nuclear enhanced green ﬂuorescent protein (EGFP)
sequence allowing direct monitoring of electroporated cells (6). As expected,
EGFP was restricted to the epithelium after 32 h. However, cMYC immuno-
reactivity demonstrated that Noggin was efﬁciently secreted and spread
throughout the surrounding mesenchyme (supplementary Fig. 2). We next
assayed for pSmad1,5,8 in the pancreas 24 and 48 h after electroporation (Fig.
3). Electroporation with a control plasmid did not change the pattern of
endogenous pSmad1,5,8 (Fig. 3B and F), but ectopic expression of Noggin
resulted in loss of mesenchymal pSmad1,5,8 immunoreactivity around the
electroporated area (Fig. 3D and H). We could still detect pSmad1,5,8 in the
Empty vector Noggin
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FIG. 4. Ectopic Noggin expression in the pancreas results in poor
epithelial branching, precocious endocrine differentiation. Electro-
porated pancreata immunoﬂuorescently stained in whole mount as
indicated. A–D: At 24 h after electroporation with control plasmid
(A and B) and Noggin (C and D). Projected images from z-stacks
show correct speciﬁcation of the dorsal and ventral pancreas under
both conditions. B and D are identical to A and C, except that the
GFP signal was removed to show the distribution of pancreatic cell
types. E and F: Forty-eight hours after electroporation with control
plasmid (E and F) and Noggin (G and H). E and G: Projected images
from a z-stack. F and H: Optical sections from the stack. In the
control, primary branchpoint in the epithelium can be observed (F,
arrowheads) and endocrine cells are restricted to the dorsal
pancreas. The dorsal pancreas is completely unbranched after
Noggin electroporation and extends as a tubular structure anteri-
orly along the stomach (arrowheads in G and H). Numerous
endocrine cells can be seen in the ventral pancreas (arrow in G and
H). I–L: Seventy-two hours after electroporation with control plasmid (I and J) and Noggin (K and L). I and K: Projected images from a z-stack.
J and L: Optical sections from the stack. Branching is more pronounced in the controls after 72 h (J, arrowheads), and endocrine cells are still
conﬁned to the dorsal pancreas. In Noggin electroporated pancreata, almost no branching has occurred. A large cluster of pancreatic endocrine
cells can be found detached from the pancreas in the stomach mesenchyme (K and L, arrowhead). In the small remaining ventral pancreas,
numerous endocrine cells can be observed (K and L, arrow). M: Less frequently observed phenotype 48 h after noggin electroporation—the dorsal
pancreas is almost entirely converted into a large endocrine cell mass. N: Electroporation with dnALK3 has no effect on the normal pancreas
development 48 h after electroporation. See Table 1 for quantiﬁcations. dp, dorsal pancreas; vp, ventral pancreas. (A high-quality digital
representation of this ﬁgure is available in the online issue.)
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and in the dorsal neural tube (not shown). We noted that the Nkx6.1-positive
pancreas epithelium appeared less developed than the corresponding controls
after 48 h (compare Fig. 3G–E).
To assess pancreas morphogenesis, we performed whole-mount immuno-
ﬂuorescent staining of electroporated embryos at 24, 48, and 72 h. Three-
dimensional projections of confocal z-stacks were generated showing green
ﬂuorescent protein (GFP), Nkx6.1, and glucagon/insulin (Fig. 4). At 24 h after
electroporation with control plasmid or Noggin, the dorsal and ventral
pancreata were both formed normally, and endocrine cells were found
exclusively in the dorsal pancreas (Fig. 4A–D). At 48 h, the pancreata
electroporated with empty vector developed normally with primary branch-
ing, two distinct ventral pancreas buds (5), and endocrine cells conﬁned to the
dorsal pancreas (Fig. 4E and F). In contrast, development of the Noggin
electroporated pancreata was severely disturbed (Fig. 4G, H, M). There was
no primary branching of the epithelium. Instead the dorsal pancreas appeared
as a tubular structure extending anteriorly along the stomach (Fig. 4G and H).
Quantifying the amount of epithelial and endocrine areas showed that the
total endocrine area was unchanged, but the epithelium was reduced by 50%
(supplementary Table 2). Precocious endocrine cells could be observed in the
ventral pancreas which was hypoplastic (Fig. 4G and H, arrow; supplemen-
tary Table 2). In some embryos, the pancreas was almost entirely converted
into a large endocrine cluster (Fig. 4M).
At 72 h after electroporation with control vector, endocrine cells were still
conﬁned to the dorsal pancreas and branching of the epithelium was promi-
nent (Fig. 4I and J). Conversely, the pancreata of Noggin electroporated
embryos were hypomorphic, and large endocrine clusters detached from the
pancreas could be observed in the stomach mesenchyme (Fig. 4K and L,
arrowheads). There was no epithelial branching and endocrine cells were
found in the ventral pancreas (Fig. 4K and L, arrow). Cell-autonomous
inhibition of BMP signaling in the endoderm via electroporation with dnALK3
had no effect on pancreas development (Fig. 4N), suggesting that the effect
elicited by Noggin is through inhibition of BMP signaling in the mesenchyme.
In neural tube electroporation experiments, dnALK3, as well as Noggin, was
able to block Smad1,5,8 phosphorylation in the dorsal neural tube. conﬁrming
that the dnALK3 construct worked as expected (supplementary Fig. 2C–H).
The pancreas of Noggin electroporated embryos was further analyzed on
sections 48 h after electroporation (Fig. 5). The anterior extension of the
pancreas contained Nkx6.1, glucagon, and insulin-positive cells (Fig. 5A and
B). Control pancreata contained scattered exocrine cells marked by amylase
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FIG. 5. Pancreatic cell types can be observed in the stomach mesen-
chyme and exocrine differentiation is reduced 48 h after electropora-
tion with Noggin. A and B are adjacent sections at the level of the
stomach in a Noggin electroporated embryo showing Nkx6.1 mRNA
expression and insulin and glucagon protein expression, respectively.
Large clusters of pancreatic cells can be found in the stomach mesen-
chyme, and both glucagon and insulin are readily found (A and B). C
and D: Sections of the pancreas of control (C) and Noggin (D)
electroprated embryos imunoﬂurescently labeled for Amylase and
showing GFP expression in electroporated cells. in D inset: The boxed
area is without GFP. Note the absence of amylase-positive cells in the
Noggin-electroporated pancreas. (A high-quality digital representation
of this ﬁgure is available in the online issue.)
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FIG. 6. Cell autonomous BMP signaling inhibition in the mouse pancreas mesenchyme results in increased -cell differentiation. Mouse pancreas
organ cultures explanted and transduced at e12.5 (A–K) or 10.5 (L–N) with lentiviral constructs as indicated. A–C: Stereomicrographs after 3
days in culture. D–F: Stereomicrographs of three different explants of each condition after 7 days in culture. G and H: Explants transduced with
a control EGFP construct, immunﬂurescently stained for E-cadherin (red) and showing EGFP with or without DAPI nuclear counterstain. Note
how GFP expression is restricted to the mesenchyme 3 and 7 days after transduction. I–K: Explants transduced as indicated and cultured for 7
days. Immunostained for amylase (green), insulin (red), and nuclei (DAPI, blue). L–N: Explants transduced at e10.5 and cultured for 8 days, then
stained for amylase and insulin with DAPI nuclear counter stain. See Table 2 for quantiﬁcations. (A high-quality digital representation of this
ﬁgure is available in the online issue.)
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rated embryos (Fig. 5D).
Cell-autonomous BMP inhibition in the mesenchyme has a similar
effect on endocrine and exocrine differentiation as BMP inhibition by
Noggin. The results presented so far indicate that BMP signaling is required
in the mesenchyme and that the effect on the epithelium is indirect. This was
difﬁcult to demonstrate directly since electroporation in the chicken embryo
does not permit cell-autonomous inhibition of BMP signaling in the mesen-
chyme. Therefore, we took advantage of established protocols for in vitro
development of mouse pancreas explants and lentiviral gene transduction
(28). We explanted e12.5 pancreata transduced with lentivirial vectors encod-
ing either GFP, Noggin, or dnALK3. When whole pancreas explants were
exposed to lentiviral vectors, exclusive infection of the mesenchyme was
achieved (Fig. 6H and I), allowing inhibition of mesenchymal BMP signaling in
a cell-autonomous manner with dnALK3.
The explants were cultured for 3 or 7 days (Fig. 6A–F). Stereomicrographs
of the explants cultured for 7 days showed that dnALK3 and Noggin-
transduced explants had a similar morphology and were of similar size as
controls (Fig. 6A–F). Costaining for E-cadherin and GFP on GFP-transduced
explants conﬁrmed the mesenchymal-speciﬁc expression after 3 and 7 days in
culture (Fig. 6H and I). We quantiﬁed the number of exocrine cells and -cells
after 7 days in culture (Fig. 6J–L, supplementary Table 3) and found a 2.8-fold
increase in the relative area of -cells in dnALK3-transduced explants com-
pared with controls. This expansion was even more pronounced in Noggin-
transduced explants which showed a 3.6-fold increase in relative -cell area.
In contrast, the relative exocrine area was diminished in dnALK3 and
Noggin-transduced explants compared with controls (not statistically signiﬁ-
cant). There was no obvious branching defect in these studies, which could be
a result of different timing of BMP inhibition compared with the studies
performed in chicken. We therefore repeated the experiments with e10.5
explants prior to branching morphogenesis. E10.5 gut tubes were dissected;
transduced with GFP, Noggin, or dnALK3; and cultured for 4 and 8 days. After
4 days, the total explant volume was reduced by 5.5- and 1.8-fold when
transduced with Noggin and dnALK3, respectively (compared with control
GFP transduction; supplementary Fig. 3E). Noggin transduction resulted in a
subtle change in the overall branching pattern, visualized by whole-mount
Mucin-1 staining, as main ducts were not well deﬁned and appeared diffuse
compared with controls (supplementary Fig. 3A–D). After 8 days in culture,
mesenchymal Noggin expression increased the total number of insulin-
positive cells by 3.8-fold, whereas the total number of amylase-positive cells
were reduced by 1.6-fold (Fig. 6M–O, supplementary Table 3). Similarly,
mesenchymal expression of dnALK3 increased the number of insulin-positive
cells by 2.5-fold, demonstrating that cell autonomous BMP signal reception in
the mesenchyme is required for a normal rate of endocrine cell differentiation
to occur. We did observe a small but statistically signiﬁcant effect on total
exocrine cell numbers in Noggin-transduced explants and in relative numbers
of exocrine cells in both Noggin and dnALK3 transduced (supplementary
Table 3). The effect of mesenchymal expression of dnALK3 on branching
morphogenesis was ambiguous; some explants exhibited a phenotype similar
to the Noggin-transduced explants, whereas some had a normal appearance
(not shown). We speculate that this may be attributed to variable transduction
efﬁciency.
Mesenchymal gene expression is severely affected by Noggin-mediated
BMP inhibition. Since our results suggested that Noggin inhibited BMP
signaling in the mesenchyme, we next investigated mesenchymal gene expres-
sion patterns. Pitx2 is normally expressed in the left side of the mesenchyme
of vertebrate embryos and is involved in asymmetrical organ development
(29,30). Bapx1 was recently demonstrated to be involved in the left-sided
lateral growth of the e10.5 mouse dorsal pancreas because of a requirement
for Bapx1 in the formation of a specialized mesothelial structure, the
splancnic mesodermal plate (SMP) (31). It is normally expressed in the left
side of the mesenchyme, and it is required for the separation of the splenic and
pancreatic mesenchyme and maintenance of the pancreas character in the
distal part of the dorsal pancreas (31,32). To evaluate the expression of Pitx2
and Bapx1 in relation to the chicken pancreas, we ﬁrst performed mRNA in
situ hybridizations on serial sections for Nkx6.1 and Shh, together with Pitx2
and Bapx1 (supplementary Fig. 4). We found that, as in the mouse, Bapx1 was
initially expressed bilaterally in the pancreas region (supplementary Fig. 4P),
but from e3 strong expression was restricted to the Pitx2-positive mesen-
chyme on the left side of the pancreas (supplementary Fig. 4I, J, L, and M).
Bapx1 appeared to be symmetrically expressed at the level of the stomach
(supplementary Fig. 4H) as in the mouse (31).
In control embryos, we found that Bapx1 was expressed left sided in the
pancreas mesenchyme together with Pitx2 after 48 h (Fig. 7C and E). In
contrast, Noggin-electroporated embryos displayed a duplication of Bapx1
expression, whereas Pitx2 remained left sided, suggesting that Bapx1 and
Pitx2 expression is uncoupled at least under these conditions (Fig. 7D and F).
These results are in agreement with a role for BMP signaling in development
of the pancreas mesenchyme. Since Bapx1 is involved in the formation of the
SPM in the mouse embryo, we hypothesized that this structure could be
affected in the BMP-inhibited embryos. We therefore stained for Isl1 and
laminin or Nkx6.1/Nkx2.2 with DAPI nuclear counter stain to visualize this
structure (supplementary Fig. 5). In control embryos, the SPM was asymmet-
ric with a condensation of the mesothelium on the left side at HH st. 19, 32 h
after electroporation (supplementary Fig. 5A and B). Noggin electroporated
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FIG. 7. Electroporation with Noggin results in persistence of a Bapx1-
positive pancreas mesenchyme on the right side of the pancreas 48 h
after electroporation. mRNA in situ hybridization on electroporated
embryos 48 h after electroporation. A, C, E and B, D, F are serial
sections from the same embryos, G–J are serial sections from other
embryos. Nkx6.1 staining shows the pancreas epithelium (A and B).
Pitx2 and Bapx1 are normally coexpressed on the left side of the
pancreas in control embryos (arrows, C and E). However, in Noggin-
electroporated embryos, Bapx1 expression becomes symmetrically
expressed on both sides of the pancreas (arrows, F), whereas Pitx2
remains left sided (arrow, D). Most of the unbranced dorsal pancreas
in Noggin electroporated embryos does not express Hes1 (G and H),
but the duodenum maintains Hes1 expression. dp, dorsal pancreas;
duo, duodenum; vp, ventral pancreas.
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suggesting that downregulation of right-sided Bapx1 expression is required
for establishment of the asymmetric SPM.
The observation of precocious endocrine differentiation in Noggin-electro-
porated embryos prompted us to analyze the expression of Hes1. We found
that the unbranched tubular dorsal pancreas was Hes1-negative 48 h after
electroporation, suggesting that the excessive endocrine differentiation is
coincident with downregulated Hes1 expression (Fig. 7E and K). We therefore
looked after 32 h of development and earlier (supplementary Fig. 6 and data
not shown). Most of the Nkx6.1-positive dorsal pancreas epithelium had
differentiated after 32 h and was Hes1-negative, but the remaining Nkx6.1-
positive cells expressed normal levels of Hes1. At earlier time points when the
pancreas was more normal, we could not detect a general downregulation of
Hes1 in the epithelium (not shown). We can therefore not distinguish between
loss of Hes1 followed by differentiation or vice versa, likely because our ISH
protocol does not allow quantitative measurements of mRNA expression
levels.
The angiogenic remodeling of major vessels is compromised in Noggin-
electroporated embryos. The bilateral expression of Bapx1 in the mesen-
chyme of Noggin electroporated embryos was notable. In chicken and mice,
the right omphalomesenteric vein is normally found at this position, and the
developing pancreas grows around this vessel (4,5). Gene expression changes
in this structure might indicate that the normal intimately joined development
of the pancreas and the vein was disturbed. To visualize the vasculature and
the pancreas, we injected embryos with ﬂuorescently-labeled lens culinaris
agglutin, a lectin with high afﬁnity to chicken endothelial cells (20), and
subsequently we stained for Nkx6.1 by whole-mount immunohistochemistry
(Fig. 8).
At 3 days of development (HH st. 19), the paired omphalomesenteric veins
run on each side of the gut tube and join anteriorly at the level of the liver in
the ductus venosus (33) (supplementary Fig. 7C). The bilateral, ventral Nkx6.1
domains are in close contact to these veins and the dorsal pancreas has grown
asymmetrically over the right omphalomesenteric vein (supplementary Fig.
7C). At this stage. the dorsal aorta is well separated from the pancreas by the
pancreatic mesenchyme. During the next day, a series of anastomoses of the
veins occur and most of the left omphalomesenteric vein regresses, leaving
behind the right omphalomesenteric vein which curls around the gut at the
level of the pancreas (5,33) (supplementary Fig. 7D and F). The dorsal
pancreas and one of the ventral pancreata lie in close contact to the right
omphalomesenteric vein (supplementary Fig. 7F) (5).
We analyzed the vascular development in control and Noggin electropo-
rated embryos 48 h after electroporation. The electroporated control embryos
had normal development of the omphalomesenteric vein (Fig. 8A–C). Trans-
verse vibratome sectioning revealed the asymmetric pancreas mesenchyme
(Fig. 8C), and, as expected, the dorsal aorta was well separated from the
dorsal pancreas (Fig. 8A). In Noggin electroporated embryos, the vasculature
developed abnormally (Fig. 8E–G). The omphalomesenteric vein was found
on the ventral side of the pancreas and gut (n  6) and, in some embryos, the
dorsal aortas failed to fuse and move dorsally (2 of 6 embryos). To assess the
development of the microvasculature, we made Flk1 ISH on sectioned
embryos. This revealed a normal microvasculature around the dorsal pan-
creas 32 h after electroporation when the omphalomesenteric vein is already
displaced to the ventral side in BMP-inhibited embryos (supplementary Fig.
8), suggesting that there is no general inhibition of angiogenesis under these
conditions.
DISCUSSION
Development of the pancreas depends on interactions
between the epithelium and the mesenchyme as recog-
nized since the studies by Golosow and Grobstein (12), but
few endogenous signaling factors have been identiﬁed.
Here, we used chicken in ovo endoderm electroporation
timed to express the pancreatic transgenes after speciﬁ-
cation of the pancreas. We reasoned that this would allow
us to study BMP signaling during pancreas organogenesis.
Detection of pSmad1,5,8 shows that early pancreatic mes-
enchyme receives a BMP signal, possibly through ALK3,
which is expressed in the chicken pancreas mesenchyme
(34). Since we ﬁnd BMP expression in the mesenchyme, it
is possible that an autocrine signaling mechanism is
occurring. Epithelial expression of the secreted BMP
antagonist Noggin resulted in the loss of pSmad1,5,8
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FIG. 8. Vascular/pancreatic development in electroporated embryos 48 h after electroporation. Embryos perfused with a ﬂuorescently-tagged
Lens Culinaris Agglutinin (labeling the vascular endothelium) and subjected to whole-mount immunostaing for Nkx6.1 and GFP. A,B and E,F
show projected z-stacks from lateral views at two different magniﬁcations. C and G: Projected images from transverse thick vibratome sections
from the same embryos (indicated by dashed lines in A and E). Note how the dorsal aorta is well separated from the pancreas in the control and
how the dorsal pancreas curls around the omphalomesenteric vein. In Noggin-electroporated embryos, the omphalomesenteric vein is consistently
found ventrally to the pancreas, and in some of the embryos, the paired dorsal aortas fail to fuse. The bisymmetrical mesenchyme is indicated by
dashed lines in F. (The contrast was temporarily enhanced in the image to allow the drawing based on a background signal. The mesenchyme is
not readily observable at the published contrast setting). D and H: Schematic drawing summarizing the relationship between the gut and pancreas
(green) and the omphalomesenteric vein (red). D is drawn similar to a study done by Romanoff (33). a, aorta; dp, dorsal pancreas; duo, duodenum;
dv, ductus venosus; li, liver; ov, omphalomesenteric vein; vp, ventral pancreas. (A high-quality digital representation of this ﬁgure is available in
the online issue.)
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fected epithelial and mesenchymal development. The epi-
thelium displayed reduced branching, anterior extension
of the dorsal pancreas into the stomach mesenchyme, and
precocious endocrine differentiation.
Inhibiting BMP signaling compromised angiogenic re-
modeling that positions the right omphalomesenteric vein
adjacent to the pancreas. Instead, we observed a persis-
tence of mesenchymal Bapx1 expression, a bilateral SMP,
and failure of the dorsal aortas to fuse in the most severely
affected embryos. We cannot distinguish a direct effect on
the endothelial cells from an indirect effect acting through
the mesenchyme. However, the microvasculature seems
normal in BMP-inhibited embryos, suggesting that some
aspects of angiogenesis occur normally and the defect
appears limited to major vessels. Notably, the mouse
explants corroborate the ﬁndings in chick, arguing against
involvement of the major vessels. Additionally, mesenchy-
mal Isl1 expression, dependent on signals from blood
vessels (35), is maintained.
The results presented herein appear to conﬂict with a
recent report by Goulley et al. (16). In that study, BMP
signaling was perturbed by the expression of Noggin and
BMP4 in the pancreas epithelium using the Pdx1 pro-
moter, with no profound effect on pancreatic develop-
ment. We speculate that this could be due to different
levels of expression since establishment of high-express-
ing transgenic mouse lines used in their studies would be
prevented by a severe vascular or pancreatic phenotype
caused by embryonic or perinatal lethality, and thus a
selection for low expressers. A similar study expressing
Bmp6 under the control of the Pdx1 promoter resulted in
complete pancreas agenesis at a late gestational age, and
these mice displayed a hypomorphic spleen, suggesting
that the mesenchyme was also affected (15).
The present study suggests that there is no epithelial
BMP signaling in the pancreas at the investigated stages,
and that the effect on epithelial development is secondary
to inhibition of BMP signaling in the mesenchyme. This is
supported by the observation that cell autonomous BMP-
signaling inhibition in the mouse pancreas mesenchyme
leads to an increase in endocrine differentiation concom-
itant with a decrease in exocrine development. It is
possible that the effect of BMP inhibition on the mesen-
chyme can be subdivided into an inhibition of an autocrine
mesenchymal signal and an associated effect on vascular
remodelling. BMP signaling in the mesenchyme may be
required for the mesenchyme to express a secondary
factor acting on the epithelium. Fgf10 is one candidate
because mesenchymal Fgf10 is required for epithelial
branching and progenitor cell proliferation (9–11). How-
ever, there is little Fgf10 expression left at e12.5, the time
of explanting in some of the organ culture experiments,
suggesting that other factors could be involved.
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